Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10919183 [patent_doc_number] => 20140322201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'METHODS OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/139096 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9780 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14139096 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/139096
METHODS OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES Dec 22, 2013 Abandoned
Array ( [id] => 9615758 [patent_doc_number] => 20140205616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 14/109213 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 79689 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14109213 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/109213
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR Dec 16, 2013 Abandoned
Array ( [id] => 10911780 [patent_doc_number] => 20140314794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 14/108820 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 79677 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14108820 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/108820
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR Dec 16, 2013 Abandoned
Array ( [id] => 16956067 [patent_doc_number] => 11059910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Anti-CD47 antibodies and methods of use thereof [patent_app_type] => utility [patent_app_number] => 14/095395 [patent_app_country] => US [patent_app_date] => 2013-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 32 [patent_no_of_words] => 41578 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095395 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/095395
Anti-CD47 antibodies and methods of use thereof Dec 2, 2013 Issued
Array ( [id] => 14883549 [patent_doc_number] => 10421801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-24 [patent_title] => Cytotoxic factors for modulating cell death [patent_app_type] => utility [patent_app_number] => 14/075994 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 15632 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075994 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/075994
Cytotoxic factors for modulating cell death Nov 7, 2013 Issued
Array ( [id] => 9839769 [patent_doc_number] => 20150031851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'HMGN2 PEPTIDES AND RELATED MOLECULES THAT SELECTIVELY HOME TO TUMOR BLOOD VESSELS AND TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 14/067858 [patent_app_country] => US [patent_app_date] => 2013-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20919 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14067858 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/067858
HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells Oct 29, 2013 Issued
Array ( [id] => 9560678 [patent_doc_number] => 20140178391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'COLON DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/057434 [patent_app_country] => US [patent_app_date] => 2013-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 41919 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057434 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/057434
COLON DISEASE TARGETS AND USES THEREOF Oct 17, 2013 Abandoned
Array ( [id] => 10380697 [patent_doc_number] => 20150265704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'IGM THERAPY IN PREVENTION OF ONSET, PROGRESSION, AND RECURRENCE OF AUTOIMMUNE TYPE 1 DIABETES' [patent_app_type] => utility [patent_app_number] => 14/434179 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25418 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434179 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/434179
IGM THERAPY IN PREVENTION OF ONSET, PROGRESSION, AND RECURRENCE OF AUTOIMMUNE TYPE 1 DIABETES Oct 7, 2013 Abandoned
Array ( [id] => 9269670 [patent_doc_number] => 20140024588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'METHOD FOR INDUCING SUSTAINED IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 14/045576 [patent_app_country] => US [patent_app_date] => 2013-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5820 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045576 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/045576
METHOD FOR INDUCING SUSTAINED IMMUNE RESPONSE Oct 2, 2013 Abandoned
Array ( [id] => 10529006 [patent_doc_number] => 09255134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Lytic domain fusion constructs and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 14/038631 [patent_app_country] => US [patent_app_date] => 2013-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 33 [patent_no_of_words] => 29648 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038631 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/038631
Lytic domain fusion constructs and methods of making and using same Sep 25, 2013 Issued
Array ( [id] => 12037647 [patent_doc_number] => 09815866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'Peptides that bind to epithelial cell adhesion molecule' [patent_app_type] => utility [patent_app_number] => 14/428017 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 9301 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428017 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/428017
Peptides that bind to epithelial cell adhesion molecule Sep 11, 2013 Issued
Array ( [id] => 9449373 [patent_doc_number] => 20140120543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'EXPRESSION OF ISOFORM 202 OF ERCC1 FOR PREDICTING RESPONSE TO CANCER CHEMOTHERAPY' [patent_app_type] => utility [patent_app_number] => 14/021316 [patent_app_country] => US [patent_app_date] => 2013-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11235 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14021316 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/021316
EXPRESSION OF ISOFORM 202 OF ERCC1 FOR PREDICTING RESPONSE TO CANCER CHEMOTHERAPY Sep 8, 2013 Abandoned
Array ( [id] => 9306012 [patent_doc_number] => 20140044686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'MOLECULAR MARKER FOR CANCER STEM CELL' [patent_app_type] => utility [patent_app_number] => 13/967410 [patent_app_country] => US [patent_app_date] => 2013-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 15510 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967410 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/967410
Molecular marker for cancer stem cell Aug 14, 2013 Issued
Array ( [id] => 10654739 [patent_doc_number] => 20160000884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'Liquid Factor VIII Formulations' [patent_app_type] => utility [patent_app_number] => 14/420564 [patent_app_country] => US [patent_app_date] => 2013-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15474 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420564 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/420564
Liquid Factor VIII Formulations Aug 12, 2013 Abandoned
Array ( [id] => 9634309 [patent_doc_number] => 20140212418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'Therapeutic Antibodies' [patent_app_type] => utility [patent_app_number] => 13/955785 [patent_app_country] => US [patent_app_date] => 2013-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7693 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13955785 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/955785
Therapeutic Antibodies Jul 30, 2013 Abandoned
Array ( [id] => 10325993 [patent_doc_number] => 20150210997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'METHODS AND COMPOUNDS FOR REDUCING THREONYL-tRNA SYNTHETASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/416356 [patent_app_country] => US [patent_app_date] => 2013-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37233 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416356 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/416356
Methods and compounds for reducing threonyl-tRNA synthetase activity Jul 23, 2013 Issued
Array ( [id] => 9222479 [patent_doc_number] => 20140017254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'Identification of Tumor-Associated Antigens for Diagnosis and Therapy' [patent_app_type] => utility [patent_app_number] => 13/946302 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 23462 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946302 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/946302
Identification of Tumor-Associated Antigens for Diagnosis and Therapy Jul 18, 2013 Abandoned
Array ( [id] => 10281667 [patent_doc_number] => 20150166664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'NOVEL THERAPEUTIC TREATMENTS WITH ANTI-HER2 ANTIBODIES HAVING A LOW FUCOSYLATION' [patent_app_type] => utility [patent_app_number] => 14/412797 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 46856 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412797 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/412797
NOVEL THERAPEUTIC TREATMENTS WITH ANTI-HER2 ANTIBODIES HAVING A LOW FUCOSYLATION Jul 17, 2013 Abandoned
Array ( [id] => 9318406 [patent_doc_number] => 20140050744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 13/945052 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 79664 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945052 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/945052
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR Jul 17, 2013 Abandoned
Array ( [id] => 9147811 [patent_doc_number] => 20130302334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'BCL-2-LIKE PROTEIN 11 SRM/MRM ASSAY' [patent_app_type] => utility [patent_app_number] => 13/942574 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8954 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13942574 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/942574
BCL-2-like protein 11 SRM/MRM assay Jul 14, 2013 Issued
Menu